An outbreak of severe coagulopathy from synthetic cannabinoids tainted with Long-Acting anticoagulant rodenticides

2019 ◽  
Vol 58 (8) ◽  
pp. 821-828 ◽  
Author(s):  
Jason M. Devgun ◽  
Arkady Rasin ◽  
Theresa Kim ◽  
Mark B. Mycyk ◽  
Sean M. Bryant ◽  
...  
Blood ◽  
2019 ◽  
Vol 133 (9) ◽  
pp. 902-905 ◽  
Author(s):  
Gowthami M. Arepally ◽  
Thomas L. Ortel

Abstract Recent multistate outbreaks of coagulopathy caused by brodifacoum-tainted synthetic cannabinoids or “fake weed” highlight the public health impact of long-acting anticoagulant rodenticides (LAARs). Patients presenting with this syndrome have had recent exposure to synthetic cannabinoids, evidence of isolated vitamin K antagonism with or without bleeding, and detectable levels of brodifacoum and other LAARs in circulation. This article will provide information on synthetic cannabinoids, LAARs, and coagulopathic manifestations arising from use of adulterated synthetic cannabinoids and their management.


2021 ◽  
Vol 22 (4) ◽  
pp. 1014-1019
Author(s):  
Erik Wright ◽  
John Hafner ◽  
Gregory Podolej ◽  
Douglas Feinstein ◽  
Richard van Breemen ◽  
...  

Introduction: Synthetic cannabinoids are a rapidly expanding subset of designer drugs widely available in the United States since 2008. In Illinois during the spring of 2018, over 160 documented cases of bleeding and prolonged coagulopathy occurred secondary to contaminated synthetic cannabinoids. Methods: We conducted a retrospective cohort study consisting of 38 patients to describe the initial emergency department (ED) presentation, diagnosis, and treatment. Results: Through serum testing we found that three long-acting anticoagulant rodenticides (LAAR) were detected in patients who had inhaled these tainted products: brodifacoum, difenacoum, and bromodialone. Discussion: This study encompasses the largest ED presentation of LAAR poisoning via the inhalational route known to date. Conclusion: The emergency physician should be aware of the potential for tainted coingestants as the cause of undifferentiated coagulopathy.


Medicine ◽  
2019 ◽  
Vol 98 (36) ◽  
pp. e17015 ◽  
Author(s):  
Mona N. Bahouth ◽  
Peggy Kraus ◽  
Kathryn Dane ◽  
Manuela Plazas Montana ◽  
William Tsao ◽  
...  

2021 ◽  
Vol 5 (1) ◽  
pp. 93-96
Author(s):  
Richard B. van Breemen ◽  
John W. Hafner ◽  
Daniel G. Nosal ◽  
Douglas L. Feinstein ◽  
Israel Rubinstein

2019 ◽  
Vol 94 (8) ◽  
pp. 1646-1647 ◽  
Author(s):  
Maidah Yaqoob ◽  
Douglas L. Feinstein ◽  
Israel Rubinstein

2017 ◽  
pp. bcr-2017-222170 ◽  
Author(s):  
Danielle Reimer ◽  
Melissa Smith ◽  
Sayed Ali

Sign in / Sign up

Export Citation Format

Share Document